Clearside Biomedical announces 1-for-15 reverse stock split, authorized shares reduced to 26.7M

Clearside Biomedical, Inc.

Reverse stock split at 1-for-15 ratio; effective 5:00 p.m. ET on Sept 12, 2025.
Authorized shares reduced from 400M to 26,666,666; no change to par value.
Trading on split-adjusted basis on Nasdaq Capital Market starting Sept 15, 2025; new CUSIP 185063203.
No fractional shares; cash paid in lieu; proportionate adjustments to stock options, RSUs, warrants.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.